News | October 09, 2022
Pfizer acquires Global Blood Therapeutics
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
Transformation to pure-play Innovative Medicines company nears completion
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Nutrigenomics is the study of how genes and diet (nutrients) interact. Gene variants (genetic differences) predict how an individual’s body will respond to certain nutrients.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
Subscribe To Our Newsletter & Stay Updated
